UBLCP1: Ubiquitin-Like Domain Containing CTD Phosphatase 1
A key regulator of RNA polymerase II transcription and proteasome function
Gene Information Card
| Symbol | UBLCP1 |
|---|---|
| Full Name | Ubiquitin-Like Domain Containing CTD Phosphatase 1 |
| Gene Type | Protein coding |
| Chromosomal Location | 5q33.3 |
| NCBI Gene ID | 93487 ncbi.nlm.nih.gov/gene/93487 |
| Ensembl ID | ENSG00000113580 |
| UniProt ID | Q8NHP8 |
| OMIM ID | 617245 |
| HGNC ID | 28780 |
| Aliases | CTD phosphatase-like, FLJ22624, MSTP060 |
Description
UBLCP1 encodes a phosphatase that specifically dephosphorylates the C-terminal domain (CTD) of RNA polymerase II, thereby regulating transcription elongation and termination. It also interacts with the 26S proteasome, influencing proteasomal degradation. The protein contains an N-terminal ubiquitin-like domain and a C-terminal phosphatase domain.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Cancer (general) | UBLCP1 overexpression may alter transcription and proteasome activity, promoting tumorigenesis. | COSMIC; literature |
| Neurodevelopmental disorders | Potential role via CTD phosphorylation imbalance. | ClinVar; limited evidence |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Testis | 12.5 | Medium |
| Brain | 8.2 | Low |
| Lung | 6.1 | Low |
| Liver | 4.3 | Low |
| Kidney | 5.0 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK293 | 10.0 | Moderate expression |
| HeLa | 8.5 | Moderate expression |
| K562 | 6.2 | Low expression |
| A549 | 7.1 | Low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.497C>T (p.Thr166Ile) | Missense | <0.01% | Unknown functional impact |
| c.832G>A (p.Glu278Lys) | Missense | <0.01% | Unknown functional impact |
Mutation functional classification
Loss of Function (LOF)
No confirmed loss-of-function mutations reported.
Gain of Function (GOF)
No confirmed gain-of-function mutations reported.
Dominant Negative (DN)
No confirmed dominant-negative mutations reported.
View complete mutation data:
Gene Ontology (GO)
Pathways
• RNA polymerase II transcription termination
• Proteasome-mediated ubiquitin-dependent protein catabolic process
Protein Summary
UBLCP1 is a 45 kDa protein with an N-terminal ubiquitin-like domain and a C-terminal phosphatase domain. It specifically dephosphorylates Ser5 of the RNA polymerase II CTD, promoting transcription termination. It also binds the 19S regulatory particle of the 26S proteasome, modulating proteasomal activity. The protein is predominantly nuclear and expressed in multiple tissues.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| UBLCP1 Knockout HAP1 Cell Line | EDC07883 | Human | 134510 | Details Get a Quote |
| UBLCP1 Knockout HeLa Cell Line | EDJ-KQ35980 | Human | 134510 | Details Get a Quote |
| UBLCP1 Knockout HCT 116 Cell Line | EDJ-KQ35979 | Human | 134510 | Details Get a Quote |
| UBLCP1 Knockout A-549 Cell Line | EDJ-KQ35978 | Human | 134510 | Details Get a Quote |
| UBLCP1 Knockout HEK293 Cell Line | EDJ-KQ9342 | Human | 134510 | Details Get a Quote |